Commercial Payer Strategy & Parity
Behavioral rates too often trail comparable medical services. We build the strategy — and the parity case — to secure fair, durable commercial reimbursement and network access.
Behavioral health is essential care — and among the most under-reimbursed and most heavily managed. Fulcrum Health Partners advises psychiatry, mental health hospitals, substance use treatment, Spravato and TMS programs, ABA, and speech-language providers on parity, payer negotiations, level-of-care contracting, and reimbursement.
Demand has never been higher — yet behavioral reimbursement still lags the rest of medicine.
Roughly one in five U.S. adults lives with a mental illness, and access is stretched thin. Despite federal parity law (MHPAEA), commercial behavioral rates frequently trail comparable medical services, while prior authorization, concurrent review, and medical-necessity denials govern nearly every encounter.
Layer on the complexity of level-of-care and per-diem contracting, buy-and-bill drugs like Spravato, procedure coverage for TMS, and authorization-intensive services like ABA — and behavioral providers face a uniquely difficult reimbursement environment. That is precisely where Fulcrum works.
Figures reflect recent national industry data (SAMHSA, KFF, industry sources), 2024–2026.
Parity analysis reveals where behavioral rates fall short of comparable medical services — and the case to close the gap.
From inpatient psychiatry to specialized outpatient programs — each with its own payment model, coverage rules, and pressure points.
Outpatient and inpatient psychiatric practices and med-management groups.
Inpatient psychiatric hospitals and behavioral units — per-diem and DRG.
Detox, residential, PHP, and IOP across ASAM levels of care.
Therapy practices, group practices, and community mental health.
Buy-and-bill esketamine — REMS, drug plus observation reimbursement.
Transcranial magnetic stimulation — coverage, prior auth, and procedure coding.
Applied behavior analysis — unit-based, authorization-intensive reimbursement.
SLP, OT/PT for developmental care, and multidisciplinary pediatric therapy.
Fulcrum turns your claims and encounter data into executive dashboards. Select a profile to explore a sample payer-mix and service view.
Illustrative sample dashboard. Fulcrum builds these from your EHR and billing data by service, level of care, and payer.
Not a service menu — the parity, contracting, and authorization problems that decide behavioral margin, and the strategy and analytics that resolve them.
Behavioral rates too often trail comparable medical services. We build the strategy — and the parity case — to secure fair, durable commercial reimbursement and network access.
Detox, residential, PHP, and IOP each demand different terms. We structure per-diem and level-of-care contracts that reflect true cost and acuity.
Buy-and-bill esketamine and device-based TMS carry their own coverage, coding, and observation rules. We optimize the economics of each.
Prior authorization, concurrent review, and medical-necessity denials define behavioral cash flow. We build the strategy to reduce the drag and win appeals.
Service-, level-of-care-, and payer-level modeling that turns behavioral data into a clear view of what every payer actually pays.
We protect earned revenue and bring institutional-grade reimbursement to PE-backed and multi-site behavioral platforms.
Behavioral health carries reimbursement dynamics found nowhere else in medicine. We translate each into strategy.
Federal parity is the law — but enforcement is uneven. We build the analysis that holds payers to it.
Authorization and concurrent review govern behavioral encounters more than almost any other specialty.
ASAM and medical-necessity criteria determine coverage across the SUD and psychiatric continuum.
Buy-and-bill drugs and device-based therapy bring drug- and procedure-level reimbursement complexity.
Unit-based, authorization-heavy ABA reimbursement demands rigorous tracking and payer strategy.
Access shortfalls and telehealth policy reshape where and how behavioral care is reimbursed.
Independent by design and fluent in behavioral economics — parity, level of care, per diems, and the drug and procedure reimbursement others overlook.
No networks, no downstream fees — only your economics.
The MHPAEA analysis that holds payers to the law.
Per-diem and ASAM contracting across the continuum.
Drug, device, and unit-based reimbursement expertise.
Insight into behavioral payer behavior in every market.
Platform-grade reimbursement from diligence to exit.
Quantified analysis behind every recommendation.
Dashboards and intelligence that clarify the path.
Anonymized outcomes from Fulcrum engagements with behavioral health providers and platforms.
Level-of-care benchmarking and payer strategy lifted residential and PHP per diems to reflect true acuity and cost.
An MHPAEA parity analysis exposed below-medical behavioral rates and built the case that corrected them.
Authorization and documentation strategy cut ABA unit denials and accelerated cash flow across sites.
Executive briefings on the forces moving behavioral reimbursement — parity, level of care, Spravato and TMS access, ABA, and utilization management.
Whether you're enforcing parity, negotiating per diems, optimizing Spravato or TMS economics, or managing ABA authorizations, Fulcrum Health Partners delivers the reimbursement expertise behavioral health leaders rely on.